These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3159026)

  • 41. Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450.
    Rendić S; Kajfez F; Ruf HH
    Drug Metab Dispos; 1983; 11(2):137-42. PubMed ID: 6133718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The antifolate trimetrexate: observation of the enzyme-binding conformation.
    Hempel A; Camerman N; Mastropaolo D; Camerman A
    Acta Crystallogr C; 2000 Oct; 56 ( Pt 10)():1225-7. PubMed ID: 11025305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross resistance of pleiotropically drug resistant P338 leukemia cells to the lipophilic antifolates trimetrexate and BW 301U.
    Klohs WD; Steinkampf RW; Besserer JA; Fry DW
    Cancer Lett; 1986 Jun; 31(3):253-60. PubMed ID: 2941142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phenotype conferring selective resistance to lipophilic antifolates in Chinese hamster ovary cells.
    Sharma RC; Assaraf YG; Schimke RT
    Cancer Res; 1991 Jun; 51(11):2949-59. PubMed ID: 1674447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of trimetrexate transport in human lymphoblastoid cells and development of impaired influx as a mechanism of resistance to lipophilic antifolates.
    Fry DW; Besserer JA
    Cancer Res; 1988 Dec; 48(24 Pt 1):6986-91. PubMed ID: 2973370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.
    Galivan J; Nimec Z; Rhee M
    Cancer Res; 1987 Oct; 47(20):5256-60. PubMed ID: 2958130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of insecticide synergists on microsomal oxidation of estradiol and ethynylestradiol and on microsomal drug metabolism.
    Bolt HM; Kassel H
    Xenobiotica; 1976 Jan; 6(1):33-8. PubMed ID: 1274368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of dexmedetomidine and clonidine on human liver microsomal alfentanil metabolism.
    Kharasch ED; Hill HF; Eddy AC
    Anesthesiology; 1991 Sep; 75(3):520-4. PubMed ID: 1679616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of trimetrexate (NSC 352122) in monkeys.
    Balis FM; Lester CM; Poplack DG
    Cancer Res; 1986 Jan; 46(1):169-74. PubMed ID: 2933145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists.
    Knodell RG; Holtzman JL; Crankshaw DL; Steele NM; Stanley LN
    Gastroenterology; 1982 Jan; 82(1):84-8. PubMed ID: 6118314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pediatric phase I trial and pharmacokinetic study of trimetrexate.
    Balis FM; Patel R; Luks E; Doherty KM; Holcenberg JS; Tan C; Reaman GH; Belasco J; Ettinger LJ; Zimm S
    Cancer Res; 1987 Sep; 47(18):4973-6. PubMed ID: 2957048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of hepatic oxidative and conjugative drug metabolism in the hamster by N-substituted imidazoles.
    Ritter JK; Franklin MR
    Toxicol Lett; 1987 Mar; 36(1):51-9. PubMed ID: 3564069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of cytochrome P450 enzymes in the Australian brushtail possum, Trichosurus vulpecula: comparison with that of the rat, rabbit, sheep and chicken.
    Olkowski A; Gooneratne R; Eason C
    Vet Hum Toxicol; 1998 Aug; 40(4):208-12. PubMed ID: 9682405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quinoxaline chemistry. Part 9. Quinoxaline analogues of trimetrexate (TMQ) and 10-propargyl-5,8-dideazafolic acid (CB 3717) and its precursors. Synthesis and evaluation of in vitro anticancer activity.
    Loriga M; Vitale G; Paglietti G
    Farmaco; 1998 Feb; 53(2):139-49. PubMed ID: 9604321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clotrimazole, an inhibitor of epidermal benzo(a)pyrene metabolism and DNA binding and carcinogenicity of the hydrocarbon.
    Mukhtar H; Del Tito BJ; Das M; Cherniack EP; Cherniack AD; Bickers DR
    Cancer Res; 1984 Oct; 44(10):4233-40. PubMed ID: 6088034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conformational analysis of the lipophilic antifolate trimetrexate.
    Hoffman VA; Welsh WJ
    Cancer Biochem Biophys; 1995 Jan; 14(4):281-95. PubMed ID: 7767902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of the rat hepatic mixed-function oxidases by in vivo administration of clotrimazole.
    Rodrigues AD; Waddell PR; Ioannides C
    Res Commun Chem Pathol Pharmacol; 1988 Mar; 59(3):403-6. PubMed ID: 3363224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.